Modulating regulatory t cell activity via interleukin 35

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/24 (2006.01) A61K 39/00 (2006.01) A61K 39/39 (2006.01) A61K 39/395 (2006.01) A61P 37/04 (2006.01) C07K 14/54 (2006.01) C07K 14/715 (2006.01)

Patent

CA 2664423

Methods for regulating T cell function in a subject, particularly regulatory T cell activity are provided. Methods of the invention include administering to a subject a therapeutically effective amount of an Interleukin 35 -specific binding agent, such as an antibody or small molecule inhibitor. The invention further provides methods for enhancing the immunogenicity of a vaccine or overcoming a suppressed immune response to a vaccine in a subject, including administering to the subject a therapeutically effective amount of an IL35-specific binding agent and administering to the subject a vaccine. In one embodiment the vaccine is a cancer vaccine.

L'invention concerne des procédés servant à moduler la fonction des lymphocytes T chez un sujet, en particulier l'activité régulatrice des lymphocytes T. Les procédés de l'invention consistent à administrer à un sujet une quantité efficace du point de vue thérapeutique d'un agent fixant spécifiquement l'interleukine 35, tel qu'un anticorps ou un inhibiteur dont la molécule a une petite taille. L'invention concerne en outre des procédés servant à accroître l'immunogénicité d'un vaccin ou à surmonter le problème de suppression de réponse immunitaire à un vaccin chez un sujet, consistant à administrer au sujet une quantité efficace du point de vue thérapeutique d'un agent fixant spécifiquement l'IL35 et à administrer un vaccin au sujet. Dans un mode de réalisation le vaccin est un vaccin contre le cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modulating regulatory t cell activity via interleukin 35 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulating regulatory t cell activity via interleukin 35, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulating regulatory t cell activity via interleukin 35 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1352894

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.